ArticleEuropean journal of medical research2025
Development and validation of risk prediction models for acute kidney disease in gout patients: a retrospective study using machine learning.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Leveraging ICT Tools to Improve Kidney Health: A Comprehensive Review of Innovations in Nephrology.Healthcare (Basel, Switzerland) · 2026Review
- Literature-informed ensemble machine learning for three-year diabetic kidney disease risk prediction in type 2 diabetes: Development, validation, and deployment of the PSMMC NephraRisk model.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundLimited research has been conducted on the prevalence of acute kidney injury (AKI) and acute kidney disease (AKD) in gout patients, as well as the impact of these renal complications on patient outcomes. This study aims to develop machine learning models to predict AKI and AKD in gout patients, with the goal of deploying web-based applications to support clinicians in making informed, real-time decisions for high-risk patients.
methodsA total of 1260 gout patients admitted to a tertiary hospital between January 2020 and January 2024 were included. The dataset was split into 80% for model training and 20% for testing model performance. Nine machine learning algorithms were evaluated, with performance assessed using metrics, such as AUROC, precision, recall, and F1 score. SHAP and LIME were used to visualize feature importance and interpret model predictions. The top-performing models were integrated into a web platform to identify patients at high risk of AKI and AKD.
resultsThe incidence rates of AKI and AKD were 9.05% and 12.78%, respectively. Mortality rates were higher for patients with AKI (11.40%) and AKD (7.45%). The LightGBM model achieved excellent AUROC for predicting AKI (0.815) and AKD (0.873). SHAP visualizations revealed that the key predictors of AKI in gout patients were diuretics, serum sodium, and urate lowering; therapy agents, while predictors for AKD included age, diuretics, and AKI grade. SHAP force plots and LIME analyses provided individualized predictions. To facilitate clinical implementation, the model was simplified using the top 10 predictors while maintaining strong performance.
conclusionsThe significant incidence of AKI and AKD in gout patients warrants clinical attention. The web-based prediction model provide real-time predictions, helping clinicians identify high-risk patients and improve outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.